Management of ulcerative colitis

Results: 40



#Item
1Purines / Medicine / Clinical medicine / Azathioprine / Mercaptopurine / Inflammatory bowel disease / Thiopurine / Immunosuppressive drug / Allopurinol / Tioguanine / Management of ulcerative colitis

AZATHIOPRINE / 6-MERCAPTOPURINE TREATMENT FOR IBD PATIENTS INFORMATION SHEET This information leaflet is designed to answer common questions patients ask about their medicine. Further information can be found in the in

Add to Reading List

Source URL: www.bsg.org.uk

Language: English - Date: 2013-09-11 11:10:29
2March 31, 2015  Ajinomoto Pharmaceuticals Co., Ltd. Kissei Pharmaceutical Co., Ltd.  Ajinomoto Pharmaceuticals and Kissei announce partnership for joint development and marketing

March 31, 2015 Ajinomoto Pharmaceuticals Co., Ltd. Kissei Pharmaceutical Co., Ltd. Ajinomoto Pharmaceuticals and Kissei announce partnership for joint development and marketing

Add to Reading List

Source URL: www.ajinomoto-seiyaku.co.jp

Language: English - Date: 2015-03-30 23:15:54
3NOTE: NURSE MUST INITIAL EACH INDIVIDUAL ORDER

NOTE: NURSE MUST INITIAL EACH INDIVIDUAL ORDER

Add to Reading List

Source URL: ugotabug.med.miami.edu

Language: English - Date: 2013-09-16 11:21:56
4HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OPDIVO safely and effectively. See full prescribing information for OPDIVO. OPDIVO (nivolumab) injection, for intrav

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OPDIVO safely and effectively. See full prescribing information for OPDIVO. OPDIVO (nivolumab) injection, for intrav

Add to Reading List

Source URL: packageinserts.bms.com

Language: English - Date: 2015-03-04 21:16:39
5Aliment Pharmacol Ther 2005; 21: 1111–doi: j02458.x Comparison of two different daily dosages (2.4 vs. 1.2 g) of oral mesalazine in maintenance of remission in ulcerative colitis patients

Aliment Pharmacol Ther 2005; 21: 1111–doi: j02458.x Comparison of two different daily dosages (2.4 vs. 1.2 g) of oral mesalazine in maintenance of remission in ulcerative colitis patients

Add to Reading List

Source URL: www.drfalkpharma.ru

Language: English - Date: 2005-05-10 02:05:12
6CONSUMER MEDICINE INFORMATION  NAVELBINE® ORAL 20, 30, 40, 80 mg Soft Capsules vinorelbine tartrate  What is in this leaflet

CONSUMER MEDICINE INFORMATION NAVELBINE® ORAL 20, 30, 40, 80 mg Soft Capsules vinorelbine tartrate What is in this leaflet

Add to Reading List

Source URL: www.pierre-fabre.com.au

Language: English - Date: 2015-02-10 00:22:24
7Monoclonal antibodies / Immunosuppressants / Clinical research / Pharmacology / Infliximab / Adalimumab / Management of ulcerative colitis / Ulcerative colitis / Disease-modifying antirheumatic drug / Medicine / Health / Autoimmune diseases

PUBLIC SUMMARY DOCUMENT Product: Adalimumab, 40mg/0.8mL injection, 0.8 mL cartridges and 0.8mL syringes, Humira® Sponsor: AbbVie Pty Ltd. Date of PBAC Consideration: November[removed]. Purpose of Application

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2014-11-12 19:13:31
8PREGNANCY AND THE OSTOMATE The management of a pregnant patient with a stoma is uncommon. There is no large published series and most reviews consist of information obtained from questionnaires sent to patients who have

PREGNANCY AND THE OSTOMATE The management of a pregnant patient with a stoma is uncommon. There is no large published series and most reviews consist of information obtained from questionnaires sent to patients who have

Add to Reading List

Source URL: www.australianstoma.com.au

Language: English - Date: 2011-11-04 07:27:11
9WATAG Advisory Note RE: FORMULARY LISTING OF INFLIXIMAB (REMICADE®) FOR SEVERE ULCERATIVE COLITIS The formulary listing of infliximab for the treatment of ulcerative colitis is hereby approved according to the following

WATAG Advisory Note RE: FORMULARY LISTING OF INFLIXIMAB (REMICADE®) FOR SEVERE ULCERATIVE COLITIS The formulary listing of infliximab for the treatment of ulcerative colitis is hereby approved according to the following

Add to Reading List

Source URL: www.watag.org.au

Language: English - Date: 2012-12-16 22:40:24
10PO Box 2345, Beijing[removed], China www.wjgnet.com [removed] World J Gastroenterol 2006 October 7; 12(37): [removed]World Journal of Gastroenterology ISSN[removed]

PO Box 2345, Beijing[removed], China www.wjgnet.com [removed] World J Gastroenterol 2006 October 7; 12(37): [removed]World Journal of Gastroenterology ISSN[removed]

Add to Reading List

Source URL: www.wjgnet.com

Language: English - Date: 2012-10-11 02:40:42